Recent Progress of Nano-drug Combined with Chimeric Antigen Receptor T Cell Therapy in the Treatment of Soild Tumors
Chimeric antigen receptor T cell (CAR-T) therapy has shown remarkable success in treating hematological malignancies. However, CAR-T therapy for solid tumors is still limited due to the unique solid-tumor microenvironment and heterogeneous target antigen expression, which leads to an urgent need of...
| Auteurs principaux: | , , , |
|---|---|
| Format: | Article |
| Langue: | zho |
| Publié: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2023-01-01
|
| Collection: | Chinese Journal of Lung Cancer |
| Sujets: | |
| Accès en ligne: | http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.02 |